Search

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC, a cancer-causing gene that has remained elusive until now.

… Monday, July 28, 2014 Summary Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting MYC , a cancer-causing gene that has remained elusive until now. Many of the most effective cancer therapies available today have been developed

Researchers learn how prostate cancer cells change their type to survive treatment.

… Friday, September 2, 2022 Cancer cells are adept at developing ways to evade treatments. For example, prostate cancer prostate cancer becomes resistant to hormone therapy hormone therapy by changing a protein called the androgen receptor (AR), which plays a key role in determining cellular identity.

By identifying mutations found in a person’s cancer, this blood test can help doctors tailor treatments to those most likely to benefit.

… Monday, March 23, 2020 Summary In a study published March 23 , scientists at Memorial Sloan Kettering reported that a blood test called a liquid biopsy can identify mutations responsible for resistance to a new class of drugs called PI3K inhibitors. These medicines were recently approved for treating

Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia. The results will lead to a better understanding of the behavior of leukemic cells and may have vital clinical applications for patients recovering from chemotherapy, radiation therapy, or bone marrow transplantation.

… Monday, March 13, 2006 The below press release is from Cancer Cell and is for a study published in the March issue of Cancer Cell. Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted

… Thursday, March 9, 2023 Update:  On November 27, 2023, the U.S. Food and Drug Administration approved nirogacestat (Ogsiveo™) for adults with desmoid tumors that cannot be treated with surgery alone. The approval was based on research led by investigators at Memorial Sloan Kettering Cancer Center. Nirogacestat

Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer.

… Monday, July 31, 2017 Summary Medical oncologist Mark Kris discusses how new guidelines for preventing nausea and vomiting due to treatment can improve quality of life for people with cancer. Dr. Kris co-chaired a panel that is releasing the guidelines. The American Society of Clinical Oncology (ASCO

Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.

… Monday, November 4, 2013 Summary Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research. Watch the video, Cancer Research Advances and Trends, on YouTube. Few high school students get the opportunity to learn about cutting-edge science

philanthropist and art collector Iris Cantor has made a major commitment to Memorial Sloan Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers.

… Wednesday, April 18, 2007 Philanthropist and art collector Iris Cantor has made a major commitment to New York’s Memorial Sloan Kettering Cancer Center to create an endowed chair for a senior researcher in the field of digestive cancers. Mrs. Cantor is establishing the position with support totaling

Take a look back at some of the biggest cancer science stories from this past year.

… Monday, December 21, 2020 Summary Many advances in cancer care come from applying the insights of basic science. This past year, Memorial Sloan Kettering scientists made fundamental discoveries that have direct relevance to cancer treatment. Below are ten of our favorites. 1. Good news for people with

A team of experts at Memorial Sloan Kettering shared their insights on prostate cancer and men’s health in an Information Session for patients, caregivers and those at increased risk for the disease.

… Thursday, October 15, 2020 A team of experts at Memorial Sloan Kettering shared their insights on prostate cancer and men’s health in an Information Session for patients, caregivers and those at increased risk for the disease.   Members of the MSK community joined the session to have their most pressing